Q1 2021 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Good day, and warm welcome to the Sartorius and Sartorius Stedim Biotech Conference call on the Q1 2021 Results. Today's conference is being recorded.
At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead.
Thank you very much. Welcome, everybody, and good day. I welcome you to our today's conference call on our Q1 results for Sartorius and Sartorius Stedim Biotech Group as well. As always, I'm running this call together with our CFO, Rainer Lehmann, who will present on all the details of the numbers for Sartorius. I will just kick it off by commenting the most important highlights for Q1 of this year.
First of all, both divisions have achieved a 60-plus percent top line growth. And at the same time, a very substantial margin expansion. We will comment on that in much more detail in a minute. We have achieved strong organic growth. This should not be forgotten in light of the significant impact from our corona-related
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
